Transcriptomic analysis reveals a subset of WNT/β-CATENIN genes that are differentially regulated by DUX4 and DUX4c that discriminate between severely affected FSHD and healthy muscle biopsies, suggesting a minimal biomarker signature conserved in FSHD muscle. This evidence concerns the gene DUX4L9 and facioscapulohumeral muscular dystrophy.